iShares Biotechnology ETF (IBB) Annual Income Statement (USD)
IBB Quarterly Financials (USD)
Frequently Asked Questions About iShares Biotechnology ETF (IBB) Stock
iShares Biotechnology ETF's (IBB) last reported annual revenue was N/A.
iShares Biotechnology ETF's (IBB) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A
iShares Biotechnology ETF's(IBB) is not profitable as of its last reported annual financials.
The net profit margin for iShares Biotechnology ETF's(IBB) from its laster reported year is N/A
The return on equity (ROE) for iShares Biotechnology ETF's(IBB) from its last reported annual financials is : N/A
The return on assets (ROA) for iShares Biotechnology ETF's(IBB) from its last reported annual financials is : N/A
The return on invested capital (ROIC) for iShares Biotechnology ETF's(IBB) from its last reported annual financials is : 0.00%
The Debt to Equity ratio for iShares Biotechnology ETF's(IBB) from its last reported annual financials is : 0.00%
The dividend yield for iShares Biotechnology ETF's(IBB) from its laster reported year is 0.30%
iShares Biotechnology ETF's(IBB) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for IBB !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
